Cholesterol crystal embolism syndrome in dialysis patients: An emerging clinical diagnosis?

Blood Purification

Volumn 24, Issue 5-6, 2006, Pages 433-438

  Piccoli, Giorgina Barbara ^a   Fenoglio, Roberta ^a   Colla, Loredana ^a   Bilucaglia, Donatella ^a   Mezza, Elisabetta ^a   Burdese, Manuel ^a   Bermond, Francesca ^a   Segoloni, Giuseppe Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cholesterol crystal embolism syndrome; Corticosteroid therapy; Dialysis, daily; Hemodialysis; Peritoneal dialysis; Prostaglandin analogues

Indexed keywords

ATORVASTATIN; CORTICOSTEROID; DICOUMAROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE; PREDNISOLONE; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E1; SIMVASTATIN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL CRYSTAL EMBOLISM SYNDROME; CLINICAL ARTICLE; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG PULSE THERAPY; DRUG WITHDRAWAL; ECG ABNORMALITY; ENDOVASCULAR SURGERY; EXTENDED DAILY DIALYSIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; GRAFT FAILURE; HEART DISEASE; HEMODIAFILTRATION; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; HYPOTENSION; INFLAMMATION; KIDNEY FAILURE; MALE; MYALGIA; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SERODIAGNOSIS; SIDE EFFECT; SKIN DEFECT; SYSTEMIC DISEASE; THORAX PAIN; VASCULAR DISEASE;

AGED; ANIMALS; DIAGNOSIS, DIFFERENTIAL; EMBOLISM, CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; SYNDROME;

EID: 33845939658     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000095359     Document Type: Article

References (25)

1. Modi KS, Rao VK: Atheroembolic renal disease. J Am Soc Nephrol 2001;12:1781-1787.
2. Carvajal JA, Anderson WR, Weiss L, Grismer J, Berman R: Atheroembolism: an etiologic factor in renal insuffi ciency, gastrointestinal hemorrhages and peripheral vascular diseases. Arch Intern Med 1967;119:593-599.
3. Moldveen-Geronimus M, Merriam JC: Cholesterol embolization. Circulation 1967;35:946-953.
4. Harrington JT, Sommers SC, Kassirer JP: Atheromatous emboli with progressive renal failure. Ann Intern Med 1968;68:152-160.
5. Vidt DG: Cholesterol emboli: a common cause of renal failure. Annu Rev Med 1997;48:375-385.
6. Gibbs MB, English JC, Zirwas MJ: Livedo reticularis: an update. J Am Acad Dermatol 2005;52:1009-1019.
7. Mayo RR, Swartz RD: Redefi ning the incidence of clinically detectable atheroembolism. Am J Med 1996;100:524-529.
8. Gillerot G, Sempoux C, Pirson Y, Devuyst O: Which type of dialysis in patients with cholesterol crystal embolism? Nephrol Dial Transplant 2002;17:156-158.
9. Carron PL, Florea A, Ducloux D, Jamali M, Chalopin JM: Atheroembolic disease associated with the use of low-molecular-weight heparin during haemodialysis. Nephrol Dial Transplant 1999;14:520-521.
10. Mondragon P, Descombes E, Bollmann J, Fellay G: Penile necrosis in a haemodialysis patient: a rare manifestation of cholesterol crystal embolism. Nephrol Dial Transplant 1998;13:3233-3235.
11. Syed A, Holley JL, Piraino B: Splenic infarct presenting as sterile peritonitis with peripheral embolic phenomena. Adv Perit Dial 1993;9:202-205.
12. Peat DS, Mathieson PW: Lesson of the week: cholesterol emboli may mimic systemic vasculitis. BMJ 1996;313:546-547.
13. Scolari F, Ravani P, Pola A, Guerini S, Zubani R, Movilli E, Savoldi S, Malberti F, Maiorca R: Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003;14:1584-1590.
14. Casino FG, Basile C, Gaudiano V, Lopez T: A modifi ed algorithm of the single pool urea kinetic model. Nephrol Dial Transplant 1990;5:214-219.
15. Vonesh EF, Keshaviah PR: Applications in kinetic modeling using PD ADEQUEST. Perit Dial Int 1997;17(suppl 2):S119-S125.
16. Belenfant X, Meyrier A, Jacquot C: Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999;5:840-850.
17. Siemons L, Van den Heuvel P, Parizel G, Buyssens N, De Broe ME, Cuykens JJ: Peritoneal dialysis in acute renal failure due to cholesterol embolization: two cases of recovery of renal function and extended survival. Clin Nephrol 1987;28:205-208.
18. Theriault J, Agharazzi M, Dumont M, Pichette V, Ouimet D, Leblanc M: Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 2003;94:11-18.
19. Elinav E, Chajek-Shaul T, Stern M: Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 2002;324:268-269.
20. Hasegawa M, Sugiyama S: Apheresis in the treatment of cholesterol embolic disease. Ther Apher Dial 2003;7:435-438.
21. Takahashi T, Konta T, Nishida W, Igarashi A, Ichikawa K, Kubota I: Renal cholesterol embolic disease eff ectively treated with steroid pulse therapy. Intern Med 2003;42:1206-1209.
22. Stabellini N, Rizzioli E, Trapassi MR, Catalano C, Gilli P: Renal cholesterol microembolism: is steroid therapy eff ective? Nephron 2000;86:239-240.
23. Scolari F, Tardanico R, Zani R, Pola A, Viola BF, Movilli E, Maiorca R: Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000;36:1089-1109.
24. Hasegawa M, Kawashima S, Shikano M, Hasegawa H, Tomita M, Murakami K, Kushimoto H, Katsumata H, Toba T, Oohashi A, Hiramitsu S, Matsunaga K: The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease: a report of 5 cases. Am J Nephrol 2000;20:263-267.
25. Scoble JE: Is nihilism in the treatment of atheroembolic disease at an end? Am J Kidney Dis 1999;33:975-976.